These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8052850)

  • 41. Inhibition of allorecognition by an H-2Kb-derived peptide is evidence for a T-cell binding region on a major histocompatibility complex molecule.
    Schneck J; Munitz T; Coligan JE; Maloy WL; Margulies DH; Singer A
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8516-20. PubMed ID: 2813409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potent T cell agonism mediated by a very rapid TCR/pMHC interaction.
    Boulter JM; Schmitz N; Sewell AK; Godkin AJ; Bachmann MF; Gallimore AM
    Eur J Immunol; 2007 Mar; 37(3):798-806. PubMed ID: 17295390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis.
    Christinck ER; Luscher MA; Barber BH; Williams DB
    Nature; 1991 Jul; 352(6330):67-70. PubMed ID: 2062379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional evidence for TCR-intrinsic specificity for MHCII.
    Parrish HL; Deshpande NR; Vasic J; Kuhns MS
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3000-5. PubMed ID: 26831112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
    Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
    J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
    Messaoudi I; LeMaoult J; Nikolić-Zugić J
    J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specificity and binding properties of a single-chain T cell receptor.
    Schlueter CJ; Schodin BA; Tetin SY; Kranz DM
    J Mol Biol; 1996 Mar; 256(5):859-69. PubMed ID: 8601837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.
    Seth A; Stern LJ; Ottenhoff TH; Engel I; Owen MJ; Lamb JR; Klausner RD; Wiley DC
    Nature; 1994 May; 369(6478):324-7. PubMed ID: 8183371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
    J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How a single T cell receptor recognizes both self and foreign MHC.
    Colf LA; Bankovich AJ; Hanick NA; Bowerman NA; Jones LL; Kranz DM; Garcia KC
    Cell; 2007 Apr; 129(1):135-46. PubMed ID: 17418792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relative implication of peptide residues in binding to major histocompatibility complex class I H-2Db: application to the design of high-affinity, allele-specific peptides.
    Hudrisier D; Mazarguil H; Oldstone MB; Gairin JE
    Mol Immunol; 1995 Aug; 32(12):895-907. PubMed ID: 7565816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules.
    Kjellén P; Brunsberg U; Broddefalk J; Hansen B; Vestberg M; Ivarsson I; Engström A; Svejgaard A; Kihlberg J; Fugger L; Holmdahl R
    Eur J Immunol; 1998 Feb; 28(2):755-67. PubMed ID: 9521085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of streptavidin-based peptide-MHC oligomers (tetramers) with cell-surface TCRs.
    Stone JD; Artyomov MN; Chervin AS; Chakraborty AK; Eisen HN; Kranz DM
    J Immunol; 2011 Dec; 187(12):6281-90. PubMed ID: 22102724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low affinity interaction of peptide-MHC complexes with T cell receptors.
    Matsui K; Boniface JJ; Reay PA; Schild H; Fazekas de St Groth B; Davis MM
    Science; 1991 Dec; 254(5039):1788-91. PubMed ID: 1763329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. alpha beta T cell receptor ligand-specific oligomerization revisited.
    Baker BM; Wiley DC
    Immunity; 2001 Jun; 14(6):681-92. PubMed ID: 11420039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation.
    Holler PD; Kranz DM
    Immunity; 2003 Feb; 18(2):255-64. PubMed ID: 12594952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure and specificity of T cell receptor gamma/delta on major histocompatibility complex antigen-specific CD3+, CD4-, CD8- T lymphocytes.
    Bluestone JA; Cron RQ; Cotterman M; Houlden BA; Matis LA
    J Exp Med; 1988 Nov; 168(5):1899-916. PubMed ID: 2846743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peptidic termini play a significant role in TCR recognition.
    Wang B; Sharma A; Maile R; Saad M; Collins EJ; Frelinger JA
    J Immunol; 2002 Sep; 169(6):3137-45. PubMed ID: 12218131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
    Lee JM; McKean DJ; Watts TH
    J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.